Joseph P. Davide

3.9k citations

37 papers · 2.1k indexed · 1 hit paper · h-index 22

Co-authors: George C. Prendergast Peter F. Lebowitz John A. Lewis Laura Sepp‐Lorenzino Nancy E. Kohl Peter W. Melera Weikang Tao Robert B. Lobell
Topics: Protein Kinase Regulation and GTPase Signaling (6 papers)RNA and protein synthesis mechanisms (5 papers)Click Chemistry and Applications (4 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: Science Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States China Israel

In The Last Decade

Joseph P. Davide

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

1990 579 citations Joseph P. Davide, Julie A. Waterbury et al. profile →

Peers

Countries citing papers authored by Joseph P. Davide

Since Specialization

Citations

This map shows the geographic impact of Joseph P. Davide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph P. Davide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph P. Davide more than expected).

Fields of papers citing papers by Joseph P. Davide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph P. Davide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph P. Davide. The network helps show where Joseph P. Davide may publish in the future.

Co-authorship network of co-authors of Joseph P. Davide

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph P. Davide. A scholar is included among the top collaborators of Joseph P. Davide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph P. Davide. Joseph P. Davide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of process analytical tools for rapid monitoring of live virus vaccines in manufacturing 2022 ·Scientific Reports ·(unknown),(unknown),Joseph P. Davide,(unknown),(unknown),(unknown),Josef Vlasak,Sha Ha,(unknown),Joseph P. Califano,(unknown),Malini Mukherjee	9
2	Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO 2021 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),Sha Ha,Joseph P. Davide,Joseph P. Califano,(unknown),Richard R. Rustandi,Lawrence W. Dick,Josef Vlasak,Timothy D. Culp,Andreas R. Baudy,(unknown),Malini Mukherjee	11
3	Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation 2019 ·Molecular Therapy — Nucleic Acids ·Bruce Ng,(unknown),Yi Wang,Jessica Seitzer,Julja Burchard,Duncan Brown,Vadim Dudkin,Joseph P. Davide,Vasant Jadhav,Laura Sepp‐Lorenzino,Pedro J. Cejas	17
4	Visualization of Mitotic Arrest of Cell Cycle with Bioluminescence Imaging in Living Animals 2013 ·Molecular Imaging and Biology ·Guo‐Jun Zhang,Tsing‐Bau Chen,Joseph P. Davide,Weikang Tao,Amy Vanko,Brett Connolly,David L. Williams,Cyrille Sur	4
5	Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses 2010 ·Molecular Therapy ·Weikang Tao,Xianzhi Mao,Joseph P. Davide,Bruce Ng,Mingmei Cai,Paul A. Burke,Alan B. Sachs,Laura Sepp‐Lorenzino	57
6	Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the Liver 2010 ·Molecular Therapy ·Weikang Tao,Joseph P. Davide,Mingmei Cai,Guojun Zhang,Victoria J. South,Andrea Matter,Bruce Ng,Ye Zhang,Laura Sepp‐Lorenzino	40
7	Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment 2009 ·Molecular Therapy ·Marc Abrams,Martin L. Koser,Jessica Seitzer,(unknown),(unknown),Weimin Wang,(unknown),Xianzhi Mao,Vasant Jadhav,Joseph P. Davide,Paul A. Burke,Alan B. Sachs,Steven M. Stirdivant,Laura Sepp‐Lorenzino	165
8	Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP 2007 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Paul J. Coleman,Swati P. Mercer,John D. Schreier,Carolyn A. Buser,Eileen S. Walsh,Kelly Hamilton,Robert B. Lobell,Weikang Tao,Ronald E. Diehl,Vicki J. South,Joseph P. Davide,Nancy E. Kohl,Youwei Yan,Lawrence C. Kuo,Chunze Li,Carmen Fernández‐Metzler,Elizabeth Mahan,Thomayant Prueksaritanont,George D. Hartman	35
9	Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage 2005 ·Cancer Cell ·Weikang Tao,Victoria J. South,Yun Zhang,Joseph P. Davide,(unknown),Nancy E. Kohl,Laura Sepp‐Lorenzino,Robert B. Lobell	228
10	Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I 2004 ·Bioorganic & Medicinal Chemistry Letters ·Christopher J. Dinsmore,C. Blair Zartman,Jeffrey M. Bergman,Marc Abrams,Carolyn A. Buser,Joseph Culberson,Joseph P. Davide,Michelle Ellis-Hutchings,Christine Fernandes,Samuel Graham,George D. Hartman,Hans E. Huber,Robert B. Lobell,Scott D. Mosser,R. Robinson,Theresa M. Williams	8
11	A Cell-Based Radioligand Binding Assay for Farnesyl: Protein Transferase Inhibitors 2003 ·SLAS DISCOVERY ·Robert B. Lobell,Joseph P. Davide,Nancy E. Kohl,H. Donald Burns,Waisi Eng,Raymond E. Gibson	1
12	The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases 2002 ·Bioorganic & Medicinal Chemistry Letters ·Thomas J. Tucker,Marc Abrams,Carolyn A. Buser,Joseph P. Davide,Michelle Ellis-Hutchings,Christine Fernandes,W. Wayt Gibbs,Samuel Graham,George D. Hartman,Hans E. Huber,Dongming Liu,Robert B. Lobell,William C. Lumma,R. Robinson,John T. Sisko,Anthony M. Smith	13
13	Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jeffrey M. Bergman,Donna Wei,C. Blair Zartman,Joseph P. Davide,Ian Greenberg,Dongming Liu,Timothy J. O’Neill,W. Wayt Gibbs,Kenneth S. Koblan,Nancy E. Kohl,Robert B. Lobell,I‐Wu Chen,Debra A. McLoughlin,Timothy Olah,Samuel Graham,George D. Hartman,Theresa M. Williams	22
14	Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman,Marc Abrams,Joseph P. Davide,Ian Greenberg,R. Robinson,Carolyn A. Buser,Hans E. Huber,Kenneth S. Koblan,Nancy E. Kohl,Robert B. Lobell,Samuel Graham,George D. Hartman,Theresa M. Williams,Christopher J. Dinsmore	25
15	Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Passive Immunization with Immune Globulin 1997 ·The Journal of Infectious Diseases ·Stanley M. Lemon,Paula C. Murphy,P. J. Provost,(unknown),Joseph P. Davide,Timothy Schofield,David R. Nalin,John A. Lewis	32
16	Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors. 1996 ·PubMed ·George C. Prendergast,Joseph P. Davide,Peter F. Lebowitz,Robert J. Wechsler‐Reya,Nancy E. Kohl	39
17	Evidence that Farnesyltransferase Inhibitors Suppress Ras Transformation by Interfering with Rho Activity 1995 ·Molecular and Cellular Biology ·Peter F. Lebowitz,Joseph P. Davide,George C. Prendergast	181
18	Development of the formalin-inactivated hepatitis A vaccine, VAQTATM from the live attenuated virus strain CR326F 1993 ·Journal of Hepatology ·Marcy E. Armstrong,(unknown),Joseph P. Davide,(unknown),Julie A. Waterbury,(unknown),Robert D. Keys,P. J. Provost,John A. Lewis	39
19	Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A 1992 ·Vaccine ·Edward F. Ellerbeck,John A. Lewis,David R. Nalin,Kenneth Gershman,William J. Miller,Marcy E. Armstrong,Joseph P. Davide,(unknown),(unknown),Gary Calandra,P. J. Provost,Karen Midthun	22
20	Differential utilization of poly (A) signals between DHFR alleles in CHL cells 1992 ·Nucleic Acids Research ·Kathleen W. Scotto,(unknown),Joseph P. Davide,Peter W. Melera	6

About Joseph P. Davide

Joseph P. Davide is a scholar working on Hepatology, Molecular Biology and Cell Biology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), RNA and protein synthesis mechanisms (5 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Virology (508 citations), Infectious Diseases (392 citations) and Hepatology (163 citations). Joseph P. Davide has collaborated with scholars based in United States, China and Israel. Frequent co-authors include George C. Prendergast, Peter F. Lebowitz, John A. Lewis, Laura Sepp‐Lorenzino, Nancy E. Kohl, Peter W. Melera, Weikang Tao, Robert B. Lobell, Julie A. Waterbury and Victoria J. South. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact